Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine. This exhaustion is influenced by immune checkpoint receptors, which are ...

The integration of clinical data and single-cell analyses highlights NK cell exhaustion as a key factor, offering insights with potential therapeutic implications. The work will be of interest to ...

Specifically, there were significant changes in the composition and function of the innate immune system, including an increase of mononuclear phagocytes (MPs) and NK cells, as well as enhanced ...

4Research Unit of NK Cell Study, Chinese Academy of Medical Sciences, Beijing, China. Search for other works by this author on: 1Biomedical Sciences and Health Laboratory of Anhui Province, Division ...

Base Therapeutics announced that its in house-developed NK510 cell injection—the world’s first base-edited universal NK cell product—has received IND approvals in both China and the United States.

TYRO protein tyrosine kinase-binding protein (TYROBP), also known as DNAX-activation protein 12 (DAP12) and killer cell activating receptor-associated protein (KARAP), is the adaptor protein that ...

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...